NeuroMetrix, Inc. Announces Date for 2013 Third Quarter Financial Results Conference Call WALTHAM, Mass. --(BUSINESS WIRE)--Oct. 16, 2013-- NeuroMetrix, Inc. (Nasdaq: NURO) today said it plans to issue its 2013 third quarter financial results before the opening of the market on October 23, 2013 .
NeuroMetrix Enters into Agreement with Rehabilitation Management Group, Inc. and OsteoArthritis Centers of America to Make SENSUS Pain Management System Available in its Affiliated Clinics WALTHAM, Mass. --(BUSINESS WIRE)--Oct. 15, 2013-- NeuroMetrix, Inc.
NeuroMetrix Appoints David Van Avermaete to Board of Directors WALTHAM, Mass. --(BUSINESS WIRE)--Oct. 1, 2013-- NeuroMetrix, Inc. (Nasdaq: NURO), a medical device company focused on the treatment and management of chronic pain, peripheral neuropathies, and related neurological disorders, today
NeuroMetrix To Exhibit at Medtrade Tradeshow and Conference WALTHAM, Mass. --(BUSINESS WIRE)--Sep. 30, 2013-- NeuroMetrix, Inc. (Nasdaq: NURO), a medical device company focused on the treatment and management of chronic pain, peripheral neuropathies, and related neurological disorders, today
NeuroMetrix Enters Into Agreement with Simplex Healthcare for Distribution of the SENSUS Pain Management System WALTHAM, Mass. --(BUSINESS WIRE)--Sep. 24, 2013-- NeuroMetrix, Inc. (Nasdaq: NURO), a medical device company focused on management of chronic pain and peripheral neuropathies, today
NeuroMetrix to Present at Rodman & Renshaw Annual Global Investment Conference WALTHAM, Mass. --(BUSINESS WIRE)--Sep. 3, 2013-- NeuroMetrix, Inc. (Nasdaq: NURO), a medical device company focused on management of chronic pain and peripheral neuropathies, today announced that Shai N.
NeuroMetrix, Inc. Announces Date for 2013 Second Quarter Financial Results Conference Call WALTHAM, Mass. --(BUSINESS WIRE)--Jul. 17, 2013-- NeuroMetrix, Inc. (Nasdaq: NURO), today said it plans to issue its 2013 second quarter financial results before the opening of the market on July 25, 2013 .
